VERTEX PHARMACEUTICALS INC
Quarter 2026Q1 · CUSIP 92532F100
Size · Holdings
$10.4B
#55 · 12 Holders
Total market value held across tracked managers.
Force · Net Flow
$242M
#114 · estimated
This quarter's net buying (est. Σ share change × current price).
Consensus · Breadth
+0
6▲ 6▼
Net-buying groups minus net-selling groups (related filers count once).
Who's adding
capital_group+$1.7B
two_sigma+$167M
marshall_wace+$53M
aqr+$12M
fisher+$3M
tweedy_browne+$553K
Who's trimming
point72-$4M
bridgewater-$6M
rentec-$37M
citadel-$71M
millennium-$136M
norges-$1.4B
Compiled from public SEC 13F-HR filings for a sample of 64 tracked institutions — NOT the whole market. 13F covers long US-listed equity only (no shorts, derivatives, or non-US holdings) and lags ~45 days. Net flow is estimated from share changes × current-quarter price. Institutional-behavior observation, not investment advice.